Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Santhera Pharmaceutical Holding AG

+ Add to Watchlist

SPHDF:US

93.3000 USD 8.4500 9.96%

As of 20:10:04 ET on 01/08/2015.

Snapshot for Santhera Pharmaceutical Holding AG (SPHDF)

Open: 93.3000 Day's Range: 93.3000 - 93.3000 Volume: 100
Previous Close: 84.8500 52wk Range: 4.3900 - 108.7500 1-Yr Rtn: -

Stock Chart for SPHDF

No chart data available.
  • SPHDF:US 93.3000
  • 1D
  • 1M
  • 1Y
84.8500
Interactive SPHDF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SPHDF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) -1.1800
Est. PEG Ratio -
Market Cap (M USD) 458.26
Shares Outstanding (M) 4.91
30 Day Average Volume 34
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SPHDF

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for SPHDF

Santhera Pharmaceuticals is a drug discovery and development company. The Company focuses on the discovery, preclinical and clinical development, and commercialization of pharmaceuticals for neuromuscular and metabolic diseases.

Martin GertschChairmanThomas MeierChief Executive Officer
More Company Profile & Key Executives for SPHDF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil